Brief: Sensei Biotherapeutics Reports Second Quarter 2022 Financial Results
09/08/2022 12:39
Aug 9 (Reuters) - Sensei Biotherapeutics Inc SNSE.O :
* SENSEI BIOTHERAPEUTICS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
* SENSEI BIOTHERAPEUTICS INC - STRONG BALANCE SHEET WITH
CASH
RUNWAY INTO Q1 OF 2025
* SENSEI BIOTHERAPEUTICS INC QTRLY NET LOSS PER SHARE, BASIC
AND
DILUTED $0.34
Source text for Eikon: ID:nGNX4700Sy
Further company coverage: SNSE.O
Recent news on Faeth Therapeutics
See all newsU.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
Faeth Therapeutics rises after FDA grants fast-track status for cancer drug
Brief: Faeth Therapeutics Announces FDA Grant Of Fast Track Designation For Piktor Plus Paclitaxel In Biomarker-Selected Advanced Endometrial Cancer
Brief: Faeth Therapeutics Strengthens Executive Team With Senior Leadership Appointments